Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ADVB

Advanced Biomed Inc

Feb 10 • 10:22AM ET

0.2400

+0.0025 1.05 %

Healthcare • Diagnostics & Research • Taiwan • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.00	Insider Own	72.86%	Shs Outstand	21.64M	Perf Week	-13.42%
Market Cap	5.19M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.87M	Perf Month	-33.13%
Enterprise Value	5.16M	PEG	-	EPS next Q	-	Inst Own	1.22%	Short Float	4.12%	Perf Quarter	-40.89%
Income	-0.11M	P/S	-	EPS this Y	-	Inst Trans	103.25%	Short Ratio	0.44	Perf Half Y	-36.17%
Sales	0.00M	P/B	52.75	EPS next Y	-	ROA	-61.13%	Short Interest	0.24M	Perf YTD	-17.75%
Book/sh	0.00	P/C	57.71	EPS next 5Y	-	ROE	-158.97%	52W High	4.10 -94.15%	Perf Year	-
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	10.70% -11.88%	ROIC	-100.85%	52W Low	0.21 13.69%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.68% 10.53%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-4.26%	Oper. Margin	-	ATR (14)	0.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.92	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	33.02	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.92	EPS Q/Q	-50.00%	SMA20	-18.02%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.60	Sales Q/Q	-	SMA50	-28.69%	Rel Volume	0.00	Prev Close	0.24
Employees	31	LT Debt/Eq	0.10	Earnings	-	SMA200	-60.10%	Avg Volume	544.90K	Price	0.24
IPO	Mar 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	271	Change	1.05%

Dec-31-25 10:25AM	Advanced Biomed sells Hong Kong subsidiary for $23,000 (TipRanks) -13.82%
Dec-30-25 10:17AM	Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary (GlobeNewswire)
Sep-19-25 08:30AM	Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire) -17.18%
Mar-07-25 12:29PM	Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering (GlobeNewswire)
Mar-06-25 09:02AM	Advanced Biomed Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADVB

Advanced Biomed Inc

Upgrade your FINVIZ experience